Neuronal preconditioning by inhalational anesthetics: evidence for the role of plasmalemmal adenosine triphosphate-sensitive potassium channels
about
Xenon and sevoflurane provide analgesia during labor and fetal brain protection in a perinatal rat model of hypoxia-ischemiaNoble gas xenon is a novel adenosine triphosphate-sensitive potassium channel openerNeuroprotective role of ATP-sensitive potassium channels in cerebral ischemiaNeuroprotection provided by isoflurane pre-conditioning and post-conditioningTraumatic brain injury in mice lacking the K channel, TREK-1Activation of K(2)P channel-TREK1 mediates the neuroprotection induced by sevoflurane preconditioningArgon neuroprotection.Developmental disability in the young and postoperative cognitive dysfunction in the elderly after anesthesia and surgery: do data justify changing clinical practice?Bench-to-bedside review: Molecular pharmacology and clinical use of inert gases in anesthesia and neuroprotection.The effects of levosimendan on brain metabolism during initial recovery from global transient ischaemia/hypoxiaXENON in medical area: emphasis on neuroprotection in hypoxia and anesthesia.Application of medical gases in the field of neurobiologymiR-21 contributes to xenon-conferred amelioration of renal ischemia-reperfusion injury in mice.Pharmacokinetic analysis of the chronic administration of the inert gases Xe and Ar using a physiological based modelXenon improves neurologic outcome and reduces secondary injury following trauma in an in vivo model of traumatic brain injury.Xenon preconditioning: molecular mechanisms and biological effectsCardiac Slo2.1 Is Required for Volatile Anesthetic Stimulation of K+ Transport and Anesthetic Preconditioning.Xenon-mediated neuroprotection in response to sustained, low-level excitotoxic stressXenon and other volatile anesthetics change domain structure in model lipid raft membranes.Noble gases as cardioprotectants - translatability and mechanism.Preclinical neuroprotective actions of xenon and possible implications for human therapeutics: a narrative review.Xenon is an inhibitor of tissue-plasminogen activator: adverse and beneficial effects in a rat model of thromboembolic strokeCardiac, renal, and neurological benefits of preoperative levosimendan administration in patients with right ventricular dysfunction and pulmonary hypertension undergoing cardiac surgery: evaluation with two biomarkers neutrophil gelatinase-associatChannels of preconditioning: potassium drain that protects the brain.Adding 5 h delayed xenon to delayed hypothermia treatment improves long-term function in neonatal rats surviving to adulthood.Functional roles of ATP-sensitive potassium channel as related to anesthesia.The shaker potassium channel is no target for xenon anesthesia in short-sleeping Drosophila melanogaster mutants.Is xenon a future neuroprotectant?
P2860
Q21134579-998F04AB-16E1-46BA-9FFB-23FF0CD1DDA1Q24615367-EF6A9500-CCDE-45BC-B95A-C9C26962CF10Q27025508-A5C27ED7-8560-4ECE-B2A9-31D808078735Q33594536-26105162-4C68-48C4-9BBA-19C0BD02311CQ33771759-913F6300-278E-41A6-BD4E-1E701DDFF217Q33773040-215820F1-FB03-45BB-9ACC-284A75AD4CBDQ33873386-DD455492-F942-45F9-B921-9D392DB53E0BQ34124787-FBB388D8-B895-4099-BD76-39FD259788CEQ34153156-68749459-1EC3-4542-94F0-EDDD300090CDQ34392888-FCA6BC97-73CD-4B75-9C68-F98F763FEC0FQ34570042-17D42FD4-193A-45E4-9010-3B18D2403DD1Q35595815-718DF3DD-2C02-441A-B8F7-16514C68A9F1Q35597122-C8008B22-F07F-46F1-89C5-2045FB20BF4DQ35780933-4360DF3B-8489-429E-8AA9-2A63AD54C895Q36198407-43BEEC0E-DFAF-45C6-AE1A-E70EB3DD2E60Q36541793-27D46C8B-3712-46E8-8F4C-FA3CF4B96C30Q36813857-43DF20DD-7FE8-4015-B9BC-6435835E2328Q37164290-338987D3-B568-458B-8C22-1C2A034D96E0Q37556440-1F0B7648-ECAD-4562-8376-A77A8BB264B5Q38264366-783F3F4C-86E5-454B-955A-10BCA77467CDQ38617718-74CF3581-3272-4ACC-836E-274A105A356AQ39908525-0BA3A013-3BFE-4412-84CC-79302EB1F9ADQ40602838-D832D3BA-3EA5-4CE2-8403-BE40320D065EQ42548952-9CBBF480-C815-4595-97F4-BB35AB5FE6B3Q47737570-03E6BC2E-3ED8-4047-A1B7-B6E811EF119FQ48212363-0638A735-8DE6-46B2-8142-16BF547CA313Q52740055-40A877C9-8695-4E60-AEEE-6B4767B6245CQ59134386-1647661B-5E78-4F8B-8E10-4BB57FB6AB34
P2860
Neuronal preconditioning by inhalational anesthetics: evidence for the role of plasmalemmal adenosine triphosphate-sensitive potassium channels
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Neuronal preconditioning by in ...... e-sensitive potassium channels
@ast
Neuronal preconditioning by in ...... e-sensitive potassium channels
@en
Neuronal preconditioning by in ...... e-sensitive potassium channels
@nl
type
label
Neuronal preconditioning by in ...... e-sensitive potassium channels
@ast
Neuronal preconditioning by in ...... e-sensitive potassium channels
@en
Neuronal preconditioning by in ...... e-sensitive potassium channels
@nl
prefLabel
Neuronal preconditioning by in ...... e-sensitive potassium channels
@ast
Neuronal preconditioning by in ...... e-sensitive potassium channels
@en
Neuronal preconditioning by in ...... e-sensitive potassium channels
@nl
P2093
P2860
P3181
P1433
P1476
Neuronal preconditioning by in ...... e-sensitive potassium channels
@en
P2093
Carsten Bantel
Mervyn Maze
Stefan Trapp
P2860
P304
P3181
P356
10.1097/ALN.0B013E31819DADC7
P407
P577
2009-05-01T00:00:00Z